他汀类药物在缺血及非缺血性慢性充血性心力衰竭中的作用
出处
《北京医学》
CAS
2006年第2期102-104,共3页
Beijing Medical Journal
参考文献16
-
1Tousoulis D,Homaei H,Ahmed N,et al.Increased plasma adhesion molecule levels in patients with heart failure who ischemic heart.Am Heart J,2001,141:277 - 280.
-
2Sebastian W,Michael G,Marc H,et al.Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme a reductase inhibitor is mediated by endothelial nitric oxide synthase.J Cardio Phar,2003,41:474 - 480.
-
3Doehner W,Schoene N,Rauchhaus M,et al.Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure:results from 2 placebocontrolled studies.Circulation,2002,105:1619- 1624.
-
4Christoph M,Tanja K,Heiko K,et al.Oxygen free radical release in human failing myocardium is associated with increased activity of racl-GTP ase and represents a target for statin treatment.Circulation,2003,108:1567-1574.
-
5Varo N,Lemos JA,Libby P,et al.Soluble CD40L risk prediction after acute coronary syndromes.Circulation,2003,108:1049.
-
6Shunji H,Hiroyuki T,Tetsuya S,et al.Fluvastatin,a 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitor,Attenuates left ventricular remodeling and failure after experimental myocardial infarction.Circulation,2002,105:868 - 873.
-
7Johann B,Paolo G,Daniela F,et al.Improvement of left ventricular renodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction.Circulation,2001,104:982 - 985.
-
8Indolfi C,Lorenzo ED,Perrino C,et al.Hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation.Circulation,2002,106:2118 - 2124.
-
9Pliquett RU,Cornish KG,Zucker IH.Statin therapy restores sympathovagal balance in experimental heart failure.J Appl Physiol,2003,95:700 - 704.
-
10Mozaffarian D,Nye R,Levy WC.Statin therapy is associated with lower mortality among patients with severe heart failure.Am J Cardiol,2004,93:1124 - 1129.
-
1孙天国,蒋玉红.β受体阻滞剂在心力衰竭生物学治疗中的应用[J].航空航天医药,2001,12(3):168-169.
-
2戴闺柱.心力衰竭生物学治疗的新认识[J].中华心血管病杂志,2000,28(4):314-316. 被引量：146
-
3赵林凤,赵琦.美托洛尔与依那普利联用治疗慢性充血性心力衰竭疗效观察[J].中国心血管病研究,2004,2(11):902-903. 被引量：4
-
4王卉,钟永云.生物学治疗在心力衰竭临床中的应用[J].中国药业,2002,11(12):66-67.
-
5周惠琼,吴东海.类风湿关节炎的生物学治疗[J].风湿病学杂志,1997,2(4):49-52.
-
6尚怀玉.慢性充血性心力衰竭生物学治疗62例临床观察[J].现代医药卫生,2003,19(2):157-158.
-
7许嘉宏,赵明中.慢性心力衰竭的非药物治疗[J].中国社区医师,2006,22(13):12-13.
-
8陈屹,曹优文.曲美他嗪治疗慢性心力衰竭40例临床观察[J].现代医药卫生,2010,26(18):2798-2799.
-
9况磊,陆菁,蔡明霞.急性左心衰竭30例急救治疗体会[J].黑龙江医药,2010,23(6):991-992. 被引量：2
-
10吴学思.慢性心力衰竭的诊断和治疗进展[J].中国实用内科杂志：临床前沿版,2006,26(3):408-410. 被引量：38
